Pfizer announces positive results from phase-III study in 20-valent Pneumococcal Conjugate Vaccine in infants in EU Read more
Pfizer announces positive top-line results from phase-III trial of pentavalent meningococcal vaccine candidate in adolescents Read more
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology Read more